2 completed, 1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Vaccines, Inactivated: new trials by email Literature Review of Vaccines, Inactivated trials Research Report on Vaccines, Inactivated
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine Recombinant SARS-CoV-2 Fusion Protein Vaccine 10μg, Recombinant SARS-CoV-2 Fusion Protein Vaccine 25μg, SARS-Cov-2 Vaccine Inactivated - COVID-19 Pandemic | Phase 2 | Unknown | Livzon Pharmaceutical Group Inc. | 150 | 2021-11-10 | 2022-03-29 |
| Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB Butantan Influenza Trivalent, Fragmented and Inactivated vaccine - Influenza | Completed | Butantan Institute | 120 | 2014-04-01 | 2016-06-30 | |
| A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months inactivated vaccine (Vero Cell) against EV71, 0/0.5ml placebo - Hand, Foot and Mouth Disease, Herpangina | Phase 3 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 10245 | 2012-01-01 | 2013-03-29 |
COVID-19 (1) · Hand, Foot and Mouth Disease (1) · Herpangina (1) · Influenza, Human (1)
Butantan Institute (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · Livzon Pharmaceutical Group Inc. (1)
China (2) · Brazil (1)
Feng-Cai Zhu, Master (1) · Ligong Lu, Dr. (1)